Journal Article

Combined liver–kidney transplantation for primary hyperoxaluria type 1 in young children

Sally R. Ellis, Sally‐Anne Hulton, Patrick J. McKiernan, Jean de Ville de Goyet and Deirdre A. Kelly

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 16, issue 2, pages 348-354
Published in print February 2001 | ISSN: 0931-0509
Published online February 2001 | e-ISSN: 1460-2385 | DOI:
Combined liver–kidney transplantation for primary hyperoxaluria type 1 in young children

Show Summary Details


Background. Primary hyperoxaluria type 1 (PH1) is a rare condition in which deficiency of the liver enzyme alanine:glyoxylate aminotransferase leads to renal failure and systemic oxalosis. Combined liver–kidney transplantation (LKT) is recommended for end‐stage renal failure (ESRF) in adults, but management of infants and young children is controversial. We retrospectively reviewed six children who underwent LKT for PH1.

Methods. The median age at diagnosis was 1.8 years (range 3 weeks to 7 years). Two children presented with severe infantile oxalosis at 3 and 9 weeks, five patients had ESRF with nephrocalcinosis and systemic oxalosis, (median duration of dialysis 1.3 years), and one had progressive chronic renal failure. Four children underwent combined LKT, one child staged liver then kidney, and one infant had an isolated liver transplant. The median age at transplantation was 8.9 years (range 1.7–15 years).

Results. Overall patient survival was four out of six. The two infants with PH1 and severe systemic oxalosis died (2 and 3 weeks post‐transplant) due to cardiovascular oxalosis and sepsis. The other four children are well at median follow‐up of 10 months (range 6 months to 7.4 years). No child developed hepatic rejection and all have normal liver function. Renal rejection occurred in three patients. Despite maximal medical management, oxalate deposits recurred in all renal grafts, contributing to graft loss in one (one of the infants who died), and significant dysfunction requiring haemodialysis post‐transplant for 6 months.

Conclusions. LKT is effective therapy for primary oxalosis with ESRF but has a high morbidity and mortality rate in children who present in infancy with nephrocalcinosis and systemic oxalosis. We feel that earlier LKT, or pre‐emptive liver transplantation, may be a better therapeutic strategy to improve the outlook for these patients.

Keywords: kidney; liver; nephrocalcinosis; primary hyperoxaluria; systemic oxalosis; transplantation

Journal Article.  3448 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.